FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1495581000168106: List of Medicines for Brand Consideration reference set (foundation metadata concept)


Status: current, Primitive. Date: 30-Sep 2020. Module: Third party reference set module

Descriptions:

Id Description Lang Type Status Case? Module
4462321000168116 List of Medicines for Brand Consideration reference set (foundation metadata concept) en Fully specified name Active Initial character case insensitive Third party reference set module
4462331000168118 List of Medicines for Brand Consideration reference set en Synonym Active Initial character case insensitive Third party reference set module
4462411000168119 List of Medicines for Brand Consideration (LMBC) reference set en Synonym Active Initial character case insensitive Third party reference set module
4462641000168118 <p>Supports the identification of AMT Medicinal Product Unit of Use (MPUU) and Medicinal Product Pack (MPP) concepts associated with the List of Medicines for Brand Consideration (LMBC) that forms part of the Active Ingredient Prescribing initiative. Under the <i>National Health (Pharmaceutical Benefits) Regulations 2017</i>, the <i>Repatriation Pharmaceutical Benefits Scheme Instrument 2013</i> and <i>MRCA Pharmaceutical Benefits Scheme Instrument 2013</i>, all PBS and RPBS prescriptions must be prepared by active ingredient, the brand may additionally be identified if a prescriber considers it necessary. The LMBC supports prescribers' decision-making regarding the inclusion of brand on a prescription.</p><p>This reference set can be used by prescribing software vendors to identify medications for brand consideration to meet Active Ingredient Prescribing requirements.</p><p><b>Target Client:&nbsp;</b>This reference set was developed by the National Clinical Terminology Service for the Australian Government Department of Health and Aged Care to support the Active Ingredient Prescribing initiative, and can be used by developers to assist with the requirements.</p> en Definition Active Case sensitive Third party reference set module


1324 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
List of Medicines for Brand Consideration reference set Is a Reference sets for Medications true Inferred relationship Some
List of Medicines for Brand Consideration reference set Is a Simple type reference set true Inferred relationship Some
List of Medicines for Brand Consideration reference set Developed by Australian Government Department of Health and Aged Care true Inferred relationship Some 1570063879

Members
epoetin alfa 1000 units/0.5 mL injection, 6 x 0.5 mL syringes
epoetin alfa 10 000 units/mL injection, syringe
epoetin alfa 10000 international units / 1 mL injection, 6 x 1 mL syringes (medicinal product pack)
epoetin alfa 2000 units/0.5 mL injection, syringe
epoetin alfa 2000 units/0.5 mL injection, 6 x 0.5 mL syringes
epoetin alfa 20 000 units/0.5 mL injection, syringe
epoetin alfa 20 000 units/0.5 mL injection, 6 x 0.5 mL syringes
epoetin alfa 3000 units/0.3 mL injection, syringe
epoetin alfa 3000 units/0.3 mL injection, 6 x 0.3 mL syringes
epoetin alfa 4000 units/0.4 mL injection, syringe
epoetin alfa 4000 units/0.4 mL injection, 6 x 0.4 mL syringes
epoetin alfa 40 000 units/mL injection, syringe
epoetin alfa 40 000 units/mL injection, 1 mL syringe
epoetin alfa 5000 international units / 0.5 mL injection, 0.5 mL syringe (medicinal product unit of use)
epoetin alfa 5000 units/0.5 mL injection, 6 x 0.5 mL syringes
epoetin alfa 6000 units/0.6 mL injection, syringe
epoetin alfa 6000 units/0.6 mL injection, 6 x 0.6 mL syringes
epoetin alfa 8000 units/0.8 mL injection, syringe
epoetin alfa 8000 units/0.8 mL injection, 6 x 0.8 mL syringes
epoetin beta 10 000 units/0.6 mL injection, syringe
epoetin beta 10 000 units/0.6 mL injection, 6 x 0.6 mL syringes
epoetin beta 2000 units/0.3 mL injection, syringe
epoetin beta 2000 units/0.3 mL injection, 6 x 0.3 mL syringes
epoetin beta 3000 units/0.3 mL injection, syringe
epoetin beta 3000 units/0.3 mL injection, 6 x 0.3 mL syringes
epoetin beta 4000 units/0.3 mL injection, syringe
epoetin beta 4000 units/0.3 mL injection, 6 x 0.3 mL syringes
epoetin beta 5000 units/0.3 mL injection, syringe
epoetin beta 5000 international units / 0.3 mL injection, 6 x 0.3 mL syringes (medicinal product pack)
epoetin beta 6000 units/0.3 mL injection, syringe
epoetin beta 6000 units/0.3 mL injection, 6 x 0.3 mL syringes
epoetin lambda 1000 units/0.5 mL injection, syringe
epoetin lambda 1000 units/0.5 mL injection, 0.5 mL syringe
epoetin lambda 1000 units/0.5 mL injection, 6 x 0.5 mL syringes
epoetin lambda 10 000 units/mL injection, syringe
epoetin lambda 10 000 units/mL injection, 1 mL syringe
epoetin lambda 10 000 units/mL injection, 6 x 1 mL syringes
epoetin lambda 2000 units/mL injection, syringe
epoetin lambda 2000 units/mL injection, 1 mL syringe
epoetin lambda 2000 units/mL injection, 6 x 1 mL syringes
epoetin lambda 3000 units/0.3 mL injection, syringe
epoetin lambda 3000 units/0.3 mL injection, 0.3 mL syringe
epoetin lambda 3000 units/0.3 mL injection, 6 x 0.3 mL syringes
epoetin lambda 4000 units/0.4 mL injection, syringe
epoetin lambda 4000 units/0.4 mL injection, 0.4 mL syringe
epoetin lambda 4000 units/0.4 mL injection, 6 x 0.4 mL syringes
epoetin lambda 5000 units/0.5 mL injection, syringe
epoetin lambda 5000 units/0.5 mL injection, 0.5 mL syringe
epoetin lambda 5000 units/0.5 mL injection, 6 x 0.5 mL syringes
epoetin lambda 6000 units/0.6 mL injection, syringe
epoetin lambda 6000 units/0.6 mL injection, 0.6 mL syringe
epoetin lambda 6000 units/0.6 mL injection, 6 x 0.6 mL syringes
epoetin lambda 8000 units/0.8 mL injection, syringe
epoetin lambda 8000 units/0.8 mL injection, 0.8 mL syringe
epoetin lambda 8000 units/0.8 mL injection, 6 x 0.8 mL syringes
estetrol 14.2 mg + drospirenone 3 mg tablet [24] (&) inert substance tablet [4], 28
estetrol 14.2 mg + drospirenone 3 mg tablet [24] (&) inert substance tablet [4], 3 x 28
estetrol 14.2 mg + drospirenone 3 mg tablet [24] (&) inert substance tablet [4], 6 x 28
nomegestrol acetate 2.5 mg + estradiol 1.5 mg tablet
nomegestrol acetate 2.5 mg + estradiol 1.5 mg tablet [24] (&) inert substance tablet [4], 28
estradiol 1.5 mg + nomegestrol acetate 2.5 mg tablet [24 tablets] (&) inert substance tablet [4 tablets], 3 x 28 tablets (medicinal product pack)
estradiol 100 microgram/24 hours patch
estradiol 100 microgram/24 hours patch, 2
estradiol 100 microgram/24 hours patch, 4
estradiol 100 microgram/24 hours patch, 8
estradiol 25 microgram/24 hours patch
estradiol 25 microgram/24 hours patch, 2
estradiol 25 microgram/24 hours patch, 4
estradiol 25 microgram/24 hours patch, 8
estradiol 37.5 microgram/24 hours patch
estradiol 37.5 microgram/24 hours patch, 8
estradiol 50 microgram/24 hours + norethisterone acetate 140 microgram/24 hours patch
estradiol 50 microgram/24 hours patch [4] (&) estradiol 50 microgram/24 hours + norethisterone acetate 140 microgram/24 hours patch [4], 8
estradiol 50 microgram/24 hours + norethisterone acetate 140 microgram/24 hours patch, 8
estradiol 50 microgram/24 hours + norethisterone acetate 250 microgram/24 hours patch
estradiol 50 microgram/24 hours patch [4] (&) estradiol 50 microgram/24 hours + norethisterone acetate 250 microgram/24 hours patch [4], 8
estradiol 50 microgram/24 hours + norethisterone acetate 250 microgram/24 hours patch, 8
estradiol 50 microgram/24 hours patch
estradiol 50 microgram/24 hours patch, 2
estradiol 50 microgram/24 hours patch, 4
estradiol 50 microgram/24 hours patch, 8
estradiol 75 microgram/24 hours patch
estradiol 75 microgram/24 hours patch, 2
estradiol 75 microgram/24 hours patch, 24
estradiol 75 microgram/24 hours patch, 4
estradiol 75 microgram/24 hours patch, 8
ethinylestradiol 10 microgram tablet
levonorgestrel 150 microgram + ethinylestradiol 30 microgram tablet [84] (&) ethinylestradiol 10 microgram tablet [7], 91
levonorgestrel 100 microgram + ethinylestradiol 20 microgram tablet
levonorgestrel 100 microgram + ethinylestradiol 20 microgram tablet [21] (&) inert substance tablet [7], 2 x 28
levonorgestrel 100 microgram + ethinylestradiol 20 microgram tablet [21] (&) inert substance tablet [7], 28
levonorgestrel 100 microgram + ethinylestradiol 20 microgram tablet [21] (&) inert substance tablet [7], 3 x 28
levonorgestrel 100 microgram + ethinylestradiol 20 microgram tablet [21] (&) inert substance tablet [7], 4 x 28
gestodene 75 microgram + ethinylestradiol 30 microgram tablet
gestodene 75 microgram + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 2 x 28
gestodene 75 microgram + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28
gestodene 75 microgram + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 3 x 28
gestodene 75 microgram + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 4 x 28
levonorgestrel 125 microgram + ethinylestradiol 30 microgram tablet
levonorgestrel 150 microgram + ethinylestradiol 30 microgram tablet
ethinylestradiol 30 microgram + levonorgestrel 150 microgram tablet [21 tablets] (&) inert substance tablet [7 tablets], 2 x 28 tablets (medicinal product pack)

Start Previous Page 4 of 14 Next End


Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start